Bioresorbable Vascular Scaffolds Manufacturer & Supplier

Leading the Future of Vascular Intervention with Innovative Biodegradable Technology

Global Landscape of Bioresorbable Vascular Scaffolds (BVS)

The global cardiovascular intervention industry has undergone a paradigm shift from traditional Bare Metal Stents (BMS) and Drug-Eluting Stents (DES) to the revolutionary Bioresorbable Vascular Scaffolds (BVS). As a premier Bioresorbable Vascular Scaffolds manufacturer, we recognize that the industry is moving toward a "leaving nothing behind" philosophy. BVS represents the fourth revolution in interventional cardiology, designed to provide temporary mechanical support to the vessel wall and then gradually dissolve, allowing the artery to regain its natural vasomotor function.

🌐

Market Maturity

While Europe and Asia-Pacific regions have been early adopters, the global market for BVS is currently experiencing a robust CAGR of over 10%. Hospitals are increasingly seeking suppliers who can provide Sirolimus-eluting bioresorbable coronary stents that balance radial strength with optimized absorption profiles.

🔬

Technological Frontier

Current industrial trends focus on thinner struts (sub-100 microns) and the application of PLLA (Poly-L-Lactic Acid) materials to minimize the risk of late stent thrombosis, a historical challenge that modern engineering has largely addressed.

Industry Trends & Future Trajectory

The evolution of vascular scaffolds is no longer just about "opening the vessel." It is about Vascular Reparative Therapy (VRT). As a professional supplier of BVS, we track several key trends that are shaping the commercial medical device landscape:

  • Hybrid Approaches: Combining bioresorbable materials with advanced imaging like OCT (Optical Coherence Tomography) for precision placement.
  • Peripheral Expansion: Moving beyond coronary arteries to treat peripheral artery disease (PAD) in the legs, where flexible scaffolds are essential to withstand biomechanical stress.
  • Customized Degradation: Developing scaffolds with variable degradation rates tailored to the specific healing timelines of different patient demographics.
2-3 Years Full Bioresorption Time
100μm Ultra-Thin Strut Tech
98% Biocompatibility Rating
50+ Countries Served

About Hangzhou SJ Medical

Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.

Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.

World-Class Manufacturing Facility

SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.

The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.

Why Global Procurement Managers Choose Us

🇨🇳

The "China Advantage"

As a leading Bioresorbable Vascular Scaffolds manufacturer in China, we offer the perfect intersection of advanced technology and cost-efficiency. Our localized supply chain and massive R&D investment allow us to provide high-end medical devices at competitive price points without compromising on quality.

⚙️

OEM & ODM Capabilities

Global medical groups require localized adaptation. We provide comprehensive OEM/ODM services, allowing international partners to customize stent dimensions, drug loading dosages, and delivery system configurations to meet local regulatory requirements.

Localized Application Scenarios

Our bioresorbable scaffolds are engineered for diverse clinical settings:

  • ✔️ Advanced Cardiac Centers: For complex PCI procedures where future re-intervention may be necessary.
  • ✔️ Pediatric Cardiology: Scaffolds that disappear as the child's heart and vessels grow.
  • ✔️ Ambulatory Surgical Centers (ASCs): Cost-effective, high-outcome solutions for outpatient vascular care.
  • ✔️ Peripheral Clinics: Specialized designs for SFA (Superficial Femoral Artery) treatments.

Certifications & Trust

SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating our strong commitment to product quality and compliance.

Production Precision

The company is equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities. These capabilities ensure high levels of manufacturing accuracy.

Our Global Footprint

SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Our products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We continue to strengthen our global presence through professional pre-sales consultation and responsive after-sales service.

All Bioresorbable Vascular Scaffolds Products